Chronic kidney disease affects an estimated 37 million people in the U.S., and for many, there is no cure. But a new research ...

The Postdoctoral Scholar will lead innovative research projects focused on the development and evaluation of immunotherapies for brain tumors, with an emphasis on CAR-T cell therapy. This position ...

Colossal’s dire wolf project is not a resurrection – it is an imitation. But that doesn’t mean it lacks value. It offers a glimpse into the possibilities of genetic science, and raises essential ...

University of Texas Permian Basin biology lecturer Irene Perry has been recognized with the Olson Award. The laurel is given to a faculty member exemplifying the highest standards of teaching and ...

The discovery could help create new "sensorially appealing foods" that improve digestion and feelings of fullness.

clonoSEQ testing for patients with MCL is currently available for clinical use as a laboratory-developed test performed at Adaptive's CLIA-certified lab in Seattle. clonoSEQ testing in MCL has also ...

Colossal Biosciences, the "de-extinction" company that gained prominence seeking to revive the woolly mammoth, said Monday it ...

Colossal Biosciences, a U.S.-based biotech firm specializing in de-extinction, has achieved a historic milestone by ...

They’re dire wolf pups, back from extinction after some 12,000 years. Dire wolves thrived during the Pleistocene Epoch, when they roamed in packs across what would later become the Americas. Standing ...

Colossal Biosciences has announced the "resurgence" of the dire wolf, a species believed to have vanished from the Earth13,000 years ago.

Scientists have brought a breed of wolf back from extinction more than 12,000 years after it last walked the earth.

Dallas-based biotech company Colossal has announced the birth of three pups bearing the DNA signatures of dire wolves, an iconic predator last ...